5-years RFS and prognostic factors study in HR-positive...

Revue d'Épidémiologie et de Santé Publique 2018 / 05 Vol. 66

5-years RFS and prognostic factors study in HR-positive HER2-negative breast cancer patients treated with neoadjuvant endocrine therapy : Pooled analysis of two phase II trials

Pulido, M., Lerebours, F., Quenel-Tueux, N., Fourme, E., Debled, M., Becette, V., Bonnefoi, H., Rivera, S., Mac Grogan, G., Mouret-Reynier, M.-A., Tunon de Lara, C., Pierga, J.-Y., Breton-Callu, C., V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
66
Language:
french
Journal:
Revue d'Épidémiologie et de Santé Publique
DOI:
10.1016/j.respe.2018.03.097
Date:
May, 2018
File:
PDF, 279 KB
french, 2018
Conversion to is in progress
Conversion to is failed